Heart Disease

Feasibility phase of trials for CABG expanded

Published in Cardiovascular Week, November 3rd, 2003

CardioTech International, Inc., (CTE) announced that it is expanding the number of hospitals and clinical investigators participating in the feasibility phase of its clinical trial for its patented CardioPass Coronary Artery Bypass Graft (CABG).

Ten leading surgeons in Brazil and Chile have agreed to participate in CardioTech's ongoing trial, pending Ethical Committee approval, representing 10 additional hospitals.

The graft was developed under the direction of Michael Szycher, a world authority on polyurethanes and one of the investigators of the artificial heart, the Heartmate. Developed over an 11 year period, the graft is fabricated of a special...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cardiovascular Week

Source: Cardiovascular Week (2003-11-03)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry